Konrad Bork

Konrad Bork's AcademicInfluence.com Rankings

Konrad Bork

Computer Science

#8881

World Rank

#9337

Historical Rank

Machine Learning

#3754

World Rank

#3800

Historical Rank

Artificial Intelligence

#4070

World Rank

#4128

Historical Rank

Database

#5875

World Rank

#6093

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Konrad Bork Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Konrad Bork's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond (2004) (638)
Hereditary angioedema: new findings concerning symptoms, affected organs, and course. (2006) (595)
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group (2014) (551)
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. (2010) (496)
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema (2010) (489)
Hereditary angioedema with normal C1-inhibitor activity in women (2000) (481)
ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis (2010) (479)
Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. (2006) (350)
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update (2018) (347)
Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group (2012) (337)
Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. (2012) (334)
Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. (2006) (318)
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. (2008) (307)
Symptoms, Course, and Complications of Abdominal Attacks in Hereditary Angioedema Due to C1 Inhibitor Deficiency (2006) (258)
WAO Guideline for the Management of Hereditary Angioedema (2012) (249)
Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. (2003) (248)
Asphyxiation by laryngeal edema in patients with hereditary angioedema. (2000) (231)
Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. (2004) (211)
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). (2007) (209)
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. (2012) (206)
Hereditary angioedema with a mutation in the plasminogen gene (2018) (198)
Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. (2008) (197)
Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. (2009) (182)
Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. (2001) (177)
HAE international home therapy consensus document (2010) (165)
Disease expression in women with hereditary angioedema. (2008) (160)
Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. (2012) (158)
Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. (2003) (157)
Autoantibody-mediated acquired deficiency of C1 inhibitor. (1987) (155)
Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. (1989) (153)
Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. (2003) (152)
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor (2017) (139)
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency (2016) (138)
Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema (2005) (135)
Economic costs associated with acute attacks and long-term management of hereditary angioedema. (2010) (131)
Hepatocellular adenomas in patients taking danazol for here ditary angiooedema (1999) (127)
Increasing incidence of eczema herpeticum: analysis of seventy-five cases. (1988) (123)
Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. (2011) (121)
A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor. (2011) (118)
Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course. (2007) (117)
Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor (2010) (111)
Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N‐terminal cleavage site of bradykinin (2019) (105)
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update (2022) (102)
Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations (2015) (96)
Pruritus precipitated by hydroxyethyl starch: a review (2005) (95)
Cutaneous Side Effects of Drugs (1987) (94)
The International/Canadian Hereditary Angioedema Guideline (2019) (94)
Canadian hereditary angioedema guideline (2014) (80)
Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. (2008) (79)
Hereditary angio‐oedema with normal C1 inhibitor in a family with affected women and men (2006) (78)
Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema (2008) (77)
Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. (2006) (77)
Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. (2002) (69)
Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedema (2008) (66)
Treatment for hereditary angioedema with normal C1‐INH and specific mutations in the F12 gene (HAE‐FXII) (2017) (66)
[WAO Guideline for the Management of Hereditary Angioedema]. (2015) (66)
Sudden upper airway obstruction in patients with hereditary angioedema. (2003) (61)
Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies. (1989) (60)
Hereditary angioedema with normal C1 inhibitor. (2013) (59)
Primary plasmacytoma of the skin. (1996) (55)
Kallikrein–kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys (2009) (52)
Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week (2010) (52)
Long‐term efficacy of danazol treatment in hereditary angioedema (2011) (50)
Diseases of the Oral Mucosa and the Lips (1996) (49)
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. (2019) (48)
Pathogenesis of paraneoplastic follicular hyperkeratotic spicules in multiple myeloma. Follicular and epidermal accumulation of IgG dysprotein and cryoglobulin. (1990) (45)
Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. (2016) (43)
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence (2020) (42)
Hereditary angioedema: an update on causes, manifestations and treatment. (2019) (41)
Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation. (2021) (40)
Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate. (2009) (40)
Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions (2008) (39)
Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management. (2013) (39)
Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review. (2013) (37)
Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. (2014) (36)
Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. (2007) (35)
Recurrent angioedema and the threat of asphyxiation. (2010) (35)
Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema (2013) (34)
Hereditary angioedema: causes, manifestations and treatment. (2006) (32)
Hereditary progressive mucinous histiocytosis in women. Report of three members in a family. (1988) (32)
A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE) (2016) (31)
Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate (2019) (30)
Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex. (2004) (29)
Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis (2000) (29)
Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor (2014) (28)
Helicobacter pylori Infection as a Triggering Factor of Attacks in Patients with Hereditary Angioedema (2007) (26)
Multifocal aplasia cutis congenita, distal limb hemimelia, and cutis marmorata telangiectatica in a patient with Adams–Oliver syndrome (1992) (25)
On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema (2018) (25)
Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation. (2018) (25)
Persistent skin ulcers, mutilations, and acro-osteolysis in hereditary sensory and autonomic neuropathy with phospholipid excretion. Report of a family. (1989) (24)
Guideline: Hereditary angioedema due to C1 inhibitor deficiency (2019) (23)
A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family (2011) (23)
Antihistamine-resistant angioedema in women with negative family history: estrogens and F12 gene mutations. (2013) (22)
Current Management Options for Hereditary Angioedema (2012) (22)
Hereditary angioedema associated with subacute cutaneous lupus erythematosus. (1989) (21)
Hereditary progressive mucinous histiocytosis. Immunohistochemical and ultrastructural studies in an additional family. (1994) (21)
Hereditary angioedema and normal C1-inhibitor activity in women (2000) (21)
Panniculitis due to potassium bromide (1998) (20)
Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections — an open multicentre trial (1989) (20)
Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence (2020) (20)
Hereditary angioedema with normal C1 inhibition (2009) (19)
An evidence based therapeutic approach to hereditary and acquired angioedema (2014) (19)
[Contraception and pregnancy in hereditary angioedema]. (2008) (18)
Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor (2015) (17)
The Expanding Spectrum of Mutations in Hereditary Angioedema. (2021) (17)
[Psoriasis and bullous pemphigoid]. (1987) (17)
Prior pregnancy and melanoma survival. (1986) (17)
Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema. (2001) (16)
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report (2021) (16)
Physical forces in blister formation. The role of colloid osmotic pressure and of total osmolality in fluid migration into the rising blister. (1978) (15)
Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema (2016) (15)
Concentration and kinetic studies of intravenous acyclovir in serum and breast milk of a patient with eczema herpeticum. (1995) (15)
Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency. (2016) (15)
Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene (2020) (15)
Diagnosis and treatment of hereditary angioedema with normal C 1 inhibitor (2010) (14)
Allergic contact dermatitis on a violinist's neck from para‐phenylenediamine in a chin rest stain (1993) (14)
Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2 (2021) (14)
Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice (2017) (14)
Effects of ethanol and acetaldehyde on phagocytic functions (2004) (13)
[Familial congenital hypotrichosis with "uncombable hair," retinal pigmentary dystrophy, juvenile cataract and brachymetacarpia: another entity of the ectodermal dysplasia group]. (1987) (13)
Blindness, tetraspasticity, and other signs of irreversible brain damage in hereditary angioedema. (2017) (13)
[Hereditary angioedema in the German-speaking region]. (1998) (12)
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey (2017) (12)
Interaction between $$C\bar 1$$ -INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria (2004) (12)
[Bromoderma tuberosum caused by anticonvulsive treatment with potassium bromide]. (1992) (11)
[Hereditary angioneurotic edema. Clinical picture, diagnosis, patient management and drug therapy]. (2008) (11)
Lichen planus: histologic involvement of an epidermoid cyst. (1983) (10)
Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: Do prednicarbate and didecyldimethylammoniumchloride form a rational combination? (1994) (10)
Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study (2019) (10)
Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants (2020) (10)
Diseases of the Lips and Mouth (2009) (10)
Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema. (2015) (10)
Fat-storing hamartoma of dermal dendrocytes. Clinical, histologic, and ultrastructural study. (1990) (10)
[Prurigo and further diagnostically significant skin symptoms in strongyloidosis]. (1988) (9)
Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries (2020) (8)
Proof‐of‐concept study of icatibant (JE 049), a bradykinin B2 receptor antagonist in treatment of hereditary angioedema (2005) (8)
Abstracts from the 10th C1-inhibitor deficiency workshop (2017) (8)
[Symptomatic scleroderma caused by bleomycin]. (1983) (8)
sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. (2020) (8)
Long-standing pigmented keloid of the ears induced by electrical torture. (1997) (8)
Hereditary Angioedema due to C1 Inhibitor Deficiency (2019) (7)
Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency (2011) (7)
Genotype‐phenotype correlations in Brazilian patients with hereditary angioedema due to C1 inhibitor deficiency (2019) (7)
Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey (2018) (7)
Increased frequency of multiple primary melanomas in hereditary familial melanoma. (1981) (7)
Hereditary angioedema in a single family with specific mutations in both plasminogen and SERPING1 genes (2020) (6)
[Multiple lymphocytoma at the point of puncture as complication of acupuncture treatment. Traumatic origin of lymphocytoma]. (1983) (6)
[Tumor-like lupus vulgaris]. (1981) (6)
Atypical facial porokeratosis of Mibelli (1991) (6)
[Multiple simultaneous hematomas of the finger and toe nails with subsequent onychomadesis in pemphigus vulgaris]. (1987) (6)
Stimulation of T cells by autologous mononuclear leukocytes and epidermal cells in psoriasis (2004) (6)
Transfer of Aciclovir from Plasma to Human Breast Milk (2000) (6)
Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema (2021) (6)
[Hypovolemic shock caused by ascites in hereditary angioedema]. (1998) (6)
[Paraffin granuloma of the penis]. (1986) (5)
Review of the Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate (2012) (5)
Acute Edema Blisters on a Skin Swelling: An Unusual Manifestation of Hereditary Angioedema. (2016) (5)
Multifocal disseminated lipoatrophy secondary to intravenous corticosteroid administration in a patient with adrenal insufficiency. (2002) (5)
[Flea bites caused by Archaeopsylla erinacei, the hedgehog flea]. (1987) (5)
Hereditary angioneurotic oedema and blood-coagulation: Interaction between C1-esterase-inhibitor and the activation factors of the proteolytic enzyme systems (1983) (5)
[Contact dermatitis caused by PVP-iodine]. (2008) (5)
[Localized cutaneous siderosis following intramuscular iron injections]. (1984) (4)
The European Register of Hereditary Angioedema: Experience and Preliminary Results (2007) (4)
[Ascites and suspected acute abdomen in hereditary angioedema due to C1 inhibitor deficiency]. (1997) (4)
[Pseudoxanthoma elasticum in pregnancy: effects on mother and child]. (1983) (4)
Metastases of malignant melanoma due to interferon alpha-2a? (1988) (4)
25 years of safety experience with C1 inhibitor concentrate in treatment of acute hereditary angioedema attacks (2011) (4)
Acquired and hereditary forms of recurrent angioedema: Update of treatment (2018) (4)
[Disseminated lichenoid form of lupus vulgaris]. (1985) (4)
[Umbilical metastasis of a gallbladder carcinoma: "Sister Mary Joseph's nodule"]. (2002) (4)
[Stigmas, symptoms and diseases of the skin in musicians]. (1993) (4)
Tamoxifen may cause life‐threatening angioedema attacks in patients with hereditary angioedema (2017) (4)
A germline mutation in the platelet‐derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis (2021) (4)
[Angioedema caused by C1-esterase inhibitor deficiency or ACE inhibitors?]. (2007) (4)
[Massive upper gastrointestinal bleeding as first clinical manifestation of pseudoxanthoma elasticum (author's transl)]. (1980) (3)
[Furuncular myiasis caused by Dermatobia hominis larva]. (1981) (3)
Current drugs in early development for hereditary angioedema: potential for effective treatment (2014) (3)
[Artificial penile nodules (tancho nodules) in Southeast Asian men]. (1985) (3)
Side Effects Of Long-Term Treatment With Danazol And Stanozolol In Hereditary Angioedema (2007) (3)
[Simulation of malignant tumors by undeclared polyvinylpyrrolidone in drugs]. (1982) (3)
Germline mutation in PDGFRB may be implicated in hereditary progressive mucinous histiocytosis. (2020) (3)
Cutaneous Adverse Drug Reactions (2009) (3)
[Pseudotumors and other drug reactions caused by not declared additional substances]. (2008) (3)
[Extrapalmoplantar skin symptoms and additional clinical, etiological and immunological aspects in particular, in Papillon-Lefevre syndrome]. (1980) (3)
[Defective polymorphonuclear leukocyte function in chronic granulomatous muco-cutaneous candidiasis (author's transl)]. (1975) (3)
[Achalasia in circumscribed scleroderma]. (2006) (2)
[Paget's disease of the vulva and breast carcinoma]. (1976) (2)
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study (2018) (2)
Frenum reduction as a treatment for periodontal atrophy. (1958) (2)
Uncommon Signs Associated with Hereditary Angioedema with Normal C1 Inhibitor. (2020) (2)
Hereditary Angioedema with Normal C1-INH with Versus without a Specific Mutation in the F12 Gene (2015) (2)
Correction to: The International/Canadian Hereditary Angioedema Guideline (2020) (2)
A review of hereditary angioedema and recombinant human C1-inhibitor treatment (2011) (2)
Hereditary angioedema: Educational review (2006) (2)
[Contraceptives and pregnancy in melanoma patients]. (1985) (2)
Pathogenesis of Hereditary Angioedema with Normal C1 Inhibitor: Evidence for Abnormalities in Plasminogen Activator Inhibitors (2015) (2)
[Hereditary angioneurotic edema. Clinical aspects and extended diagnostic and therapeutic possibilities]. (1979) (2)
European Consensus for Gynecologycal and Obstetric Management of Women with Hereditary Angioedema due to C1-Inhibitor Deficiency (HAE): PREHAEAT (2007) (2)
Genetic Analysis as a Practical Tool for Diagnosis of Hereditary Angioedema With Normal C1 Inhibitor: A Case Report. (2016) (2)
Diagnosis and treatment of common skin diseases (1990) (2)
[Hemorrhagic skin necrosis in intravascular precipitation of cryoglobulin by lymphocytic malignant lymphoma]. (1981) (2)
[Differential diagnosis and therapy of recurrent aphthae]. (1987) (2)
[Physical bases of blister formation. II. A study of the total osmotic pressure in the blister fluid of suction blisters and of "naturally" occurring blisters as well as in the serum]. (1978) (2)
[Undifferentiated cutaneous angiosarcoma of the head: identification by the endothelial marker Ulex europaeus agglutinin I]. (1985) (2)
Hereditary Angioedema Due to C1 Inhibitor Deficiency: New Findings Concerning Symptoms and Affected Organs (2006) (2)
Mutations in the Factor XII Gene in Solitary Cases of Recurrent Angioedema with Normal C1 Inhibitor Induced or Worsened by Oral Contraceptives or Hormonal Replacement Therapy (2012) (1)
[Overall progeroid aspect of the Louis-Bar syndrome: pigmentary and keratotic phenomena]. (1979) (1)
Treatment With Pasteurized C1 Inhibitor Concentrate In Skin Swelling Attacks Of Patients With Hereditary Angioedema (2007) (1)
[Physical forces in blister formation. I. Direct measurement of blister fluid colloid osmotic pressure in suction blisters and in bullous diseases (author's transl)]. (1977) (1)
New Mutations of C1 inhibitor (SERPING1/C1NH) Gene Associated with Hereditary Angioedema in a European Population (2007) (1)
[Multiple skin plasmocytomas, increased serum IgA and lack of bone marrow lesions (author's transl)]. (1975) (1)
[Skin changes in malignant diseases]. (1983) (1)
Stimulation of T lymphocytes by isolated autologous or allogeneic human epidermal cells (1984) (1)
[The chemotactic effect of blister roof, blister fluid and blister floor on polymorphonuclear leucocytes in dermatitis herpetiformis Duhring (author's transl)]. (1975) (1)
Successful Extubation With Use of C1 Esterase Inhibitor Concentrate in a Patient With Hereditary Angioedema: In Response (2000) (1)
A systematic review of the efficacy and safety of a purified, pasteurized C1 inhibitor concentrate for the treatment of patients with type I or II hereditary angioedema (2010) (1)
[Paraneoplastic multicentric reticulohistiocytosis: induced and inductable by iodine containing x-ray contrast media]. (1985) (1)
[Quantitative measurements of peripheral circulation and further angiologic aspects in patients with elastic pseudoxanthoma]. (1973) (1)
Icatibant, a Selective Bradykinin-B2 Receptor Antagonist, in Acquired Angioedema Due to C1 Inhibitor Deficiency (2011) (1)
New drug targets and future direction: icatibant (2012) (1)
[Ultrastructure of nuclear bodies in connective tissue cells of psoriatic lesions (author's transl)]. (1975) (1)
83 Hereditary Angioedema and Normal C1-Inhibitor (HAE TYPE III): A Novel Mutation in the Coagulation Factor 12 Gene (2012) (1)
[Dermatological aspects of Hildegard von Bingen's work]. (1980) (1)
Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series (2022) (1)
Efficacy of C1-Inhibitor Concentrate (Berinert®) for the Treatment of Cutaneous Attacks of Acute Hereditary Angioedema Compared to Historical Untreated Controls (2013) (1)
[Does a circumscribed melanosis secondary to malignant melanoma exist?]. (1977) (1)
[Increase of certain serum enzyme levels (GOT, LDH, CPK, MK) after body massage and its significance in dermatomyositis]. (1972) (1)
[Endocrine influences on malignant melanoma. Survival time of melanoma patients depending on the number of prior pregnancies and menopause begin]. (1981) (1)
[Dermatoses resulting from contact with plants]. (1981) (1)
Safety Evaluation of Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency (2009) (1)
Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor. (2021) (1)
[Phagocytic function of polymorphonuclear leucocytes in psoriatic inflammation (author's transl)]. (1974) (1)
[Recurring cheilitis, stomatitis and glossitis in Felty's syndrome]. (1976) (1)
[Physical forces in blister formation. II. Examination of total osmolality in blister fluid of suction blisters, "naturally" developed blisters and in serum (author's transl)]. (1978) (1)
[Naeviform porokeratosis - only a morphologic variant of porokeratosis of Mibelli (author's transl)]. (1982) (0)
C1-Esterase Inhibitor Concentrate for Acute Laryngeal Hereditary Angioedema (HAE) Attacks: Different Treatment Response Based on Dosing Regimen? (2016) (0)
Mutation Analysis in Hereditary Angioedema Identifies Patients at Risk for Developing Acute and Life Threatening Edema (2006) (0)
Genetic Analysis As a Practical Tool to Diagnose Hereditary Angioedema with Normal C1 Inhibitor: A Case Report (2015) (0)
Tamoxifen, a Trigger Factor of Hereditary Angioedema with Normal C1-INH with a Specific Mutation in the F12 Gene (HAE-FXII) (2016) (0)
[Action of some serum enzymes following whole-body muscle massage. Contribution to the problem of physical therapy in dermatomyositis]. (1971) (0)
[Life threatening laryngeal edema after minor dental treatments in hereditary angioneurotic edema]. (1979) (0)
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin (2023) (0)
Acquired C 1 Inhibitor ( Cl-INH ) Deficiency Type 11 Replacement Therapy with C 1-INH and Analysis of Patients ' C 1-INH and Anti-Cl-INH Autoantibodies (2013) (0)
[Allergy to denture materials]. (1988) (0)
[Case report of Papillon-Lefèvre syndrome]. (1980) (0)
Icatibant, a Selective Bradykinin B2 Receptor Antagonist Used in Hereditary Angioedema Due to C1 Inhibitor Deficiency (2010) (0)
[Pruritus and bile acids. Determination of sulfalithoglycocholate and glycocholate in suction blister fluid and in serum (author's transl)]. (1981) (0)
Coagulation factor XII (Hageman factor): a new angioedema gene (2007) (0)
Novel SERPING1 mutation causing Hereditary Angioedema in a Brazilian family (2009) (0)
Treatment of skin swellings with pasteurized C1 inhibitor concentrate in patients with hereditary angioedema (2007) (0)
Contents Vol. 121, 2008 (2008) (0)
Missense Mutations in the Proline-Rich Region of Coagulation Factor XII in Hereditary and Idiopathic Angioedema. (2006) (0)
165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency (2012) (0)
Gene mutations linked with hereditary angioedema in solitary angioedema patients with normal C1-INH. (2023) (0)
[Side effects of drugs on the skin]. (1992) (0)
Missense mutations of coagulation factor XII in hereditary angioedema with normal complement C1 inhibitor (2007) (0)
[Ophthalmoblennorrhea in urethral gonorrhea and consecutive iritis as well as arthropathy despite massive penicillin treatment (postgonnorheic Reiter's syndrome)]. (1972) (0)
[Formation of IgG antibodies to C1 inhibitor as the cause of life-threatening angioedema]. (1987) (0)
Impaired function of numerically augmented Fc-receptors on granulocytes in a HLA B8+ patient with palmoplantar pustulosis (2004) (0)
Currently available treatments and future treatment options for hereditary angioedema (2015) (0)
Differentialdiagnose und Operationsindikation aus dermatologischer Sicht (1991) (0)
[Reiter's syndrome following gonorrhea. Urethral gonorrhea and gonoglennorrhea with iridocyclitis and arthritis]. (1972) (0)
[Concurrence of lichen planus pemphigoides and ulcerative colitis (author's transl)]. (1981) (0)
[Epithelioma calcificans and injury?]. (1974) (0)
Der Internist (2019) (0)
Psoriasis arthropathica und Amyloidose (2004) (0)
Definitive Link of Mutation c.351delC and Development of Hereditary Angioedema in a Large Brazilian Family (2011) (0)
Clinical symptoms and treatment in hereditary angioedema with normal C1 inhibitor (2007) (0)
PSY6 THE ICATIBANT OUTCOME SURVEY:A PROSPECTIVE STUDY OF SAFETY AND EFFECTIVENESS OF ICATIBANT IN A ‘REAL WORLD' SETTING IN PATIENTS WITH HEREDITARY ANGIOEDEMA (2010) (0)
Angioedema with Negative Family History (2014) (0)
[Recurrent angioedema (Quincke's edema)-a constant problem]. (1986) (0)
[Post-meningoencephalitic benign acanthosis nigricans]. (1980) (0)
[Histamine levels in interstitial fluid of lesional and perilesional skin in patients with chronic idiopathic urticaria (author's transl)]. (1979) (0)
Hereditary Angioedema: a New Mutation of the C1 Inhibitor Gene in a Brazilian Family (2008) (0)
[Regional intra-arterial chemotherapy with Dacarbazine in isolated liver metastases of a malignant melanoma]. (2008) (0)
[Dermatoses in pregnancy]. (1990) (0)
[Unusual early changes in malignant lymphoma of the B-cell type with a low degree of malignity]. (1980) (0)
[Pathology of skin and jejunum in dermatitis herpetiformis]. (1978) (0)
Treatment of Hereditary Angioedema with the Mutation c.988A>G (p.K330E) in the Plasminogen Gene (2020) (0)
Severe Tongue Swellings In Hereditary Angioedema With A Specific Mutation In The Plasminogen Gene (2018) (0)
[Psoriasis arthropathica and amyloidosis]. (1972) (0)
Hereditary Angioedema with Normal C1-Inhibitor: Pathophysiology and Treatment (2017) (0)
[Allergic rhinitis from metal parts of dental prostheses]. (1978) (0)
[Skin manifestations in cryoglobulinemia]. (1979) (0)
Contributions EFFICACY OF DIFFERENT MEDICAL THERAPIES FOR THE TREATMENT OF ACUTE LARYNGEAL ATTACKS OF HEREDITARY ANGIOEDEMA DUE TO C 1-ESTERASE INHIBITOR DEFICIENCY (0)
The reply. (2014) (0)
453 A 26-Year Review of Long-term Safety of a Human Pasteurized C1 Inhibitor Concentrate (2012) (0)
[The histamine-release test, a new in-vitro method in the diagnosis of allergic diseases (author's transl)]. (1981) (0)
[Skin testing in allergy to denture plastics]. (1982) (0)
[Lyell's syndrome with transient bone marrow depression caused by oxyphenebutazone]. (1979) (0)
LCNG-TEFM SUBSTITUTION WITH Cl-INACTIVATOR IN PATIENTS WITH HEREDITARY AND ACQUIRED Cl-INH DEFICIENCY AND LIFE-THREATENING ANGIOEDEMA (1987) (0)
Mutation Analysis of the C1 Inhibitor Gene (2005) (0)
[Quantitative measurement of peripheral circulation and additional new angiologic aspects in patients with Pseudoxanthoma elasticum (author's transl)]. (1974) (0)
[Cutaneous leishmaniasis in an unusual location and local recurrence]. (1980) (0)
C1-Esterase Inhibitor Concentrate For Acute Attacks Of Laryngeal Edema In Hereditary Angioedema (HAE): Fixed Dosing Vs Body Weight-Adjusted Dosing (2014) (0)
[Alexander Tschirch and the interpretation of pharmacognosy]. (2001) (0)
Author response for "Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries" (2020) (0)
[Malignant melanoma in childhool]. (1977) (0)
[Mercury absorption out of ammoniated mercury ointment (author's transl)]. (1973) (0)
[What is the best prevention and therapy of bee, wasp and hornet stings?]. (1983) (0)
Acquired and Hereditary Angioedema: Pathogenesis and Therapy (1988) (0)
Prophylaxis with C1 Inhibitor Concentrate before Tooth Extractions in Patients with Hereditary Angioedema (2011) (0)
[Primary melanomatosis]. (1976) (0)
[Cardiac involvement in urticaria]. (1980) (0)
[Pregnancy after malignant melanoma. A follow-up of 23 patients]. (1985) (0)
Inheritance pattern of hereditary angioedema indicates mutation-dependent selective effects during early embryonic development. (2021) (0)
High exhaled nitric oxide levels correlate with nonadherence in acute asthmatic children (2017) (0)
Contents, Vol. 179, 1989 (1989) (0)
Currently available treatments and future treatment options for hereditary angioedema (2015) (0)
Treatment with Pasteurized C1 Inhibitor Concentrate in Abdominal Pain Attacks of Patients with Hereditary Angioedema (2006) (0)
Contents, Vol. 166, 1983 (1983) (0)
Angioedema Due To Acquired C1‐Inhibitor Deficiency: Spectrum And Treatment With C1‐Inhibitor Concentrate: 126 (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Konrad Bork?

Konrad Bork is affiliated with the following schools:

University of Mainz

Konrad Bork's Academic­Influence.com Rankings

Why Is Konrad Bork Influential?

Konrad Bork's Published Works

Published Works

What Schools Are Affiliated With Konrad Bork?

Konrad Bork's AcademicInfluence.com Rankings